Treatment News : Acetyl-L-Carnitine Promising for Neuropathy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » October 2007

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


October 1, 2007

Acetyl-L-Carnitine Promising for Neuropathy

In a recent article in the journal CNS Drugs, Michael Youle, MD, a noted HIV specialist at London’s Royal Free Hospital, claims that acetyl-L-carnitine (LAC), an over-the-counter amino acid supplement, is a promising treatment for a condition known as peripheral neuropathy. Characterized by alternating numbness, tingling and pain in the feet, legs, hands and arms, peripheral neuropathy is nerve damage that can result from the use of certain antiretroviral medications, predominantly Videx (didanosine) and Zerit (stavudine). There are currently few treatments for neuropathy, and none are highly effective.

In the article, Dr. Youle reviews several small studies that have explored whether taking LAC can protect people from developing neuropathy or treat people who have already developed it. One early study found that people who took LAC (1500 mg twice a day) showed evidence of both nerve regeneration and a reduction in painful symptoms. A somewhat larger study, published early this year, found that LAC was significantly better able than a placebo to alleviate neuropathy symptoms.

Many people with HIV have developed resistance to a number of antiretroviral medications and must use drugs like Videx and Zerit to build an effective antiretroviral regimen. Physicians need an effective method to prevent neuropathy from developing, if possible, and to treat it when prevention is not possible, writes Dr. Youle. He concludes that LAC shows promise in this regard and deserves larger studies to prove its effectiveness.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.